Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs has submitted copies of newspaper advertisements published in Financial Express and Jansatta on August 22, 2025, as required under SEBI Listing Regulations. The notices inform equity shareholders that unclaimed shares linked to the Interim Dividend for FY 2018-19 are due to be transferred to the Investor Education and Protection Fund (IEPF) under Section 124(6) of the Companies Act, 2013. The company has also sent individual notices by post to affected shareholders at their last known address. Shareholder details have been made available on the company's website at www.lalpathlabs.com for easy reference.
This is a routine compliance filing with no direct impact on stock price or operations. Shareholders who have not claimed their Interim Dividend for FY 2018-19 should act promptly to avoid having their shares transferred to the IEPF, where recovery becomes more difficult.